Literature DB >> 1986497

Severity of single-vessel coronary arterial stenosis and duration of angina as determinants of recruitable collateral vessels during balloon angioplasty occlusion.

J J Piek1, J J Koolen, G Hoedemaker, G K David, C A Visser, A J Dunning.   

Abstract

To determine the factors that influence the presence of collateral vessels during coronary occlusion, we performed standardized contrast injection of the contralateral coronary artery in 58 consecutive patients, without previous myocardial infarction, undergoing percutaneous transluminal coronary angioplasty for 1-vessel disease (left anterior descending artery in 45, right coronary artery: in 10 and left circumflex artery in 3). The presence of collateral vessels during coronary occlusion, defined as partial or complete epicardial opacification by collateral vessels of the vessel dilated, was related to clinical, angiographic and electrocardiographic parameters. The angiographic appearance of collateral vessels during balloon inflation showed a weak, although statistically significant, correlation to the percent diameter stenosis before angioplasty (r = 0.28; p = 0.03) and the duration of angina (r = 0.37; p = 0.004). By combining lesion severity with the duration of angina, collateral vessels during coronary occlusion were particularly related to a lesion severity greater than or equal to 70% and duration of angina greater than or equal to 3 months (p less than 0.001). Furthermore, the presence of collateral vessels was associated with an absence of ST-segment shift (greater than or equal to 1 mm) during 1 minute of coronary occlusion (p less than 0.001).

Entities:  

Mesh:

Year:  1991        PMID: 1986497     DOI: 10.1016/0002-9149(91)90091-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Short-term desensitization of the histamine H1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways.

Authors:  M J Smit; S M Bloemers; R Leurs; L G Tertoolen; A Bast; S W de Laat; H Timmerman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

Review 2.  The human coronary collateral circulation.

Authors:  Christian Seiler
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

3.  Influence on collateral flow of recanalising chronic total coronary occlusions: a case-control study.

Authors:  T Pohl; P Hochstrasser; M Billinger; M Fleisch; B Meier; C Seiler
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Coronary collateral vessel development after acute myocardial infarction.

Authors:  Ersan Tatli; Armađan Altun; Mutlu Büyüklü; Ahmet Barotçu
Journal:  Exp Clin Cardiol       Date:  2007

5.  The effect of electrical neurostimulation on collateral perfusion during acute coronary occlusion.

Authors:  Jessica de Vries; Rutger L Anthonio; Mike J L Dejongste; Gillian A Jessurun; Eng-Shiong Tan; Bart J G L de Smet; Ad F M van den Heuvel; Michiel J Staal; Felix Zijlstra
Journal:  BMC Cardiovasc Disord       Date:  2007-06-27       Impact factor: 2.298

Review 6.  Determinants of human coronary collaterals.

Authors:  Stefano F de Marchi
Journal:  Curr Cardiol Rev       Date:  2014-02

7.  The association between prolongation in QRS duration and presence of coronary collateral circulation in patients with acute myocardial infarction.

Authors:  Zülküf Karahan; Bernas Altıntaş; Murat Uğurlu; İlyas Kaya; Berzal Uçaman; Ali Veysel Uluğ; Rojhat Altındağ; Yakup Altaş; Mehmet Şahin Adıyaman; Önder Öztürk
Journal:  JRSM Cardiovasc Dis       Date:  2016-07-04

8.  Vascular endothelial growth factor and hypoxia-inducible factor-1α gene polymorphisms and coronary collateral formation in patients with coronary chronic total occlusions.

Authors:  Vincent Amoah; Benjamin Wrigley; Eric Holroyd; Andrew Smallwood; Angel L Armesilla; Alan Nevill; James Cotton
Journal:  SAGE Open Med       Date:  2016-06-24

9.  Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development.

Authors:  Savas Celebi; Ozlem Ozcan Celebi; Berkten Berkalp; Sinan Aydogdu; Basri Amasyali
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.